M
Matthew P. Fox
Researcher at Boston University
Publications - 337
Citations - 14658
Matthew P. Fox is an academic researcher from Boston University. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 57, co-authored 300 publications receiving 12378 citations. Previous affiliations of Matthew P. Fox include University of Minnesota & University of the Witwatersrand.
Papers
More filters
Journal ArticleDOI
Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era.
Julia Bohlius,Fabio Valeri,Mhairi Maskew,Hans Prozesky,Daniela Garone,Mazvita Sengayi,Mazvita Sengayi,Matthew P. Fox,Matthew P. Fox,Mary-Ann Davies,Matthias Egger,Matthias Egger +11 more
TL;DR: Timely initiation of ART is essential to prevent KS and KS‐associated morbidity and mortality in South Africa and other regions in Africa with a high burden of HIV.
Journal ArticleDOI
Cost and Cost-Effectiveness of Switching From Stavudine to Tenofovir in First-Line Antiretroviral Regimens in South Africa
TL;DR: The cost and cost-effectiveness of switching from d4T to tenofovir disoproxil fumarate (TDF) in South Africa is estimated and it would be highly cost effective at a price only slightly less than what is currently available.
Journal ArticleDOI
Changing the South African national antiretroviral therapy guidelines: The role of cost modelling.
Gesine Meyer-Rath,Leigh F. Johnson,Yogan Pillay,Mark Blecher,Alana T. Brennan,Alana T. Brennan,Lawrence Long,Harry Moultrie,Ian Sanne,Matthew P. Fox,Matthew P. Fox,Sydney Rosen,Sydney Rosen +12 more
TL;DR: Assessment of the cost implications to the largest ART programme in the world of adopting sets of ART guidelines issued by the World Health Organization found the modelled increase in patient numbers as a result of prevalence and uptake was substantially more than the increase resulting from additional eligibility.
Journal ArticleDOI
Retention in care and viral suppression in differentiated service delivery models for HIV treatment delivery in sub-Saharan Africa: a rapid systematic review.
Lawrence Long,Salome Kuchukhidze,Sophie Pascoe,Brooke E Nichols,Brooke E Nichols,Matthew P. Fox,Matthew P. Fox,Refiloe Cele,Caroline Govathson,Amy N Huber,David Flynn,Sydney Rosen,Sydney Rosen +12 more
TL;DR: Differentiated service delivery models for antiretroviral treatment for HIV are being scaled up in the expectation that they will better meet the needs of patients, improve the quality and efficiency of treatment delivery and reduce costs while maintaining at least equivalent clinical outcomes.
Journal ArticleDOI
Prevalence, incidence, predictors, treatment, and control of hypertension among HIV-positive adults on antiretroviral treatment in public sector treatment programs in South Africa.
Alana T. Brennan,Lise Jamieson,Nigel J. Crowther,Matthew P. Fox,Matthew P. Fox,Jaya A. George,Jaya A. George,Kaitlyn M. Berry,Andrew Stokes,Mhairi Maskew,Ian Sanne,Lawrence Long,Lawrence Long,Naseem Cassim,Sydney Rosen,Sydney Rosen +15 more
TL;DR: Older patients, males, those on nevirapine, zidovudine or stavudine, and those who are overweight/obese should be targeted for frequent blood pressure monitoring and the identification of other cardiovascular risk factors to encourage lifestyle modifications.